A citation-based method for searching scientific literature

Mark E Sherman, Laura Ichikawa, Ruth M Pfeiffer, Diana L Miglioretti, Karla Kerlikowske, Jeffery Tice, Pamela M Vacek, Gretchen L Gierach. PLoS One 2016
Times Cited: 4







List of co-cited articles
6 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A comparison of the polytomous logistic regression and joint cox proportional hazards models for evaluating multiple disease subtypes in prospective cohort studies.
Xiaonan Xue, Mimi Y Kim, Mia M Gaudet, Yikyung Park, Moonseong Heo, Albert R Hollenbeck, Howard D Strickler, Marc J Gunter. Cancer Epidemiol Biomarkers Prev 2013
42
50

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
50

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
50

Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
Douglas K Owens, Karina W Davidson, Alex H Krist, Michael J Barry, Michael Cabana, Aaron B Caughey, Chyke A Doubeni, John W Epling, Martha Kubik, C Seth Landefeld,[...]. JAMA 2019
47
50

Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model.
Jeffrey A Tice, Steven R Cummings, Rebecca Smith-Bindman, Laura Ichikawa, William E Barlow, Karla Kerlikowske. Ann Intern Med 2008
339
50

Validation studies for models projecting the risk of invasive and total breast cancer incidence.
J P Costantino, M H Gail, D Pee, S Anderson, C K Redmond, J Benichou, H S Wieand. J Natl Cancer Inst 1999
493
50

Associations of parity-related reproductive histories with ER± and HER2± receptor-specific breast cancer aetiology.
William F Anderson, Ruth M Pfeiffer, Jan Wohlfahrt, Bent Ejlertsen, Maj-Britt Jensen, Niels Kroman. Int J Epidemiol 2017
11
25

Triple-negative breast cancer.
William D Foulkes, Ian E Smith, Jorge S Reis-Filho. N Engl J Med 2010
25


Parity, lactation, and breast cancer subtypes in African American women: results from the AMBER Consortium.
Julie R Palmer, Emma Viscidi, Melissa A Troester, Chi-Chen Hong, Pepper Schedin, Traci N Bethea, Elisa V Bandera, Virginia Borges, Craig McKinnon, Christopher A Haiman,[...]. J Natl Cancer Inst 2014
121
25

Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database.
William F Anderson, Nilanjan Chatterjee, William B Ershler, Otis W Brawley. Breast Cancer Res Treat 2002
378
25

Risk factors for breast cancer according to estrogen and progesterone receptor status.
Graham A Colditz, Bernard A Rosner, Wendy Y Chen, Michelle D Holmes, Susan E Hankinson. J Natl Cancer Inst 2004
366
25

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update.
Antonio C Wolff, M Elizabeth H Hammond, David G Hicks, Mitch Dowsett, Lisa M McShane, Kimberly H Allison, Donald C Allred, John M S Bartlett, Michael Bilous, Patrick Fitzgibbons,[...]. J Clin Oncol 2013
25

Breastfeeding and breast cancer risk by receptor status--a systematic review and meta-analysis.
F Islami, Y Liu, A Jemal, J Zhou, E Weiderpass, G Colditz, P Boffetta, M Weiss. Ann Oncol 2015
80
25

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.
M Elizabeth H Hammond, Daniel F Hayes, Mitch Dowsett, D Craig Allred, Karen L Hagerty, Sunil Badve, Patrick L Fitzgibbons, Glenn Francis, Neil S Goldstein, Malcolm Hayes,[...]. J Clin Oncol 2010
25

Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.
Karla Kerlikowske, Charlotte C Gard, Jeffrey A Tice, Elad Ziv, Steven R Cummings, Diana L Miglioretti. J Natl Cancer Inst 2016
31
25

The Premenopausal Breast Cancer Collaboration: A Pooling Project of Studies Participating in the National Cancer Institute Cohort Consortium.
Hazel B Nichols, Minouk J Schoemaker, Lauren B Wright, Craig McGowan, Mark N Brook, Kathleen M McClain, Michael E Jones, Hans-Olov Adami, Claudia Agnoli, Laura Baglietto,[...]. Cancer Epidemiol Biomarkers Prev 2017
12
25

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention.
Manuel Picon-Ruiz, Cynthia Morata-Tarifa, Janeiro J Valle-Goffin, Eitan R Friedman, Joyce M Slingerland. CA Cancer J Clin 2017
246
25

Age-related crossover in breast cancer incidence rates between black and white ethnic groups.
William F Anderson, Philip S Rosenberg, Idan Menashe, Aya Mitani, Ruth M Pfeiffer. J Natl Cancer Inst 2008
87
25

A breast cancer prediction model incorporating familial and personal risk factors.
Jonathan Tyrer, Stephen W Duffy, Jack Cuzick. Stat Med 2004
665
25

Assessment of Breast Cancer Risk Factors Reveals Subtype Heterogeneity.
Johanna Holm, Louise Eriksson, Alexander Ploner, Mikael Eriksson, Mattias Rantalainen, Jingmei Li, Per Hall, Kamila Czene. Cancer Res 2017
48
25

Reproductive risk factors and breast cancer subtypes: a review of the literature.
Kristin N Anderson, Richard B Schwab, Maria Elena Martinez. Breast Cancer Res Treat 2014
186
25

Benign breast disease and the risk of breast cancer.
Lynn C Hartmann, Thomas A Sellers, Marlene H Frost, Wilma L Lingle, Amy C Degnim, Karthik Ghosh, Robert A Vierkant, Shaun D Maloney, V Shane Pankratz, David W Hillman,[...]. N Engl J Med 2005
500
25

Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer.
Rulla M Tamimi, Graham A Colditz, Aditi Hazra, Heather J Baer, Susan E Hankinson, Bernard Rosner, Jonathan Marotti, James L Connolly, Stuart J Schnitt, Laura C Collins. Breast Cancer Res Treat 2012
134
25

Established breast cancer risk factors and risk of intrinsic tumor subtypes.
Mollie E Barnard, Caroline E Boeke, Rulla M Tamimi. Biochim Biophys Acta 2015
115
25

How many etiological subtypes of breast cancer: two, three, four, or more?
William F Anderson, Philip S Rosenberg, Aleix Prat, Charles M Perou, Mark E Sherman. J Natl Cancer Inst 2014
142
25


Risk factors by molecular subtypes of breast cancer across a population-based study of women 56 years or younger.
Mia M Gaudet, Michael F Press, Robert W Haile, Charles F Lynch, Sally L Glaser, Joellen Schildkraut, Marilie D Gammon, W Douglas Thompson, Jonine L Bernstein. Breast Cancer Res Treat 2011
102
25

Divergent oestrogen receptor-specific breast cancer trends in Ireland (2004-2013): Amassing data from independent Western populations provide etiologic clues.
Maeve Mullooly, Jeanne Murphy, Gretchen L Gierach, Paul M Walsh, Sandra Deady, Thomas I Barron, Mark E Sherman, Philip S Rosenberg, William F Anderson. Eur J Cancer 2017
8
25

Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status.
Mark F Munsell, Brian L Sprague, Donald A Berry, Gary Chisholm, Amy Trentham-Dietz. Epidemiol Rev 2014
174
25

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
25


Reproductive behaviors and risk of developing breast cancer according to tumor subtype: A systematic review and meta-analysis of epidemiological studies.
Matteo Lambertini, Luigi Santoro, Lucia Del Mastro, Bastien Nguyen, Luca Livraghi, Donatella Ugolini, Fedro A Peccatori, Hatem A Azim. Cancer Treat Rev 2016
95
25

Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.
Xiaohong R Yang, Jenny Chang-Claude, Ellen L Goode, Fergus J Couch, Heli Nevanlinna, Roger L Milne, Mia Gaudet, Marjanka K Schmidt, Annegien Broeks, Angela Cox,[...]. J Natl Cancer Inst 2011
466
25

Use of alternative time scales in Cox proportional hazard models: implications for time-varying environmental exposures.
Beth Ann Griffin, Garnet L Anderson, Regina A Shih, Eric A Whitsel. Stat Med 2012
35
25

Comparison of age distribution patterns for different histopathologic types of breast carcinoma.
William F Anderson, Ruth M Pfeiffer, Graça M Dores, Mark E Sherman. Cancer Epidemiol Biomarkers Prev 2006
90
25

Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis.
Mariaelena Pierobon, Cara L Frankenfeld. Breast Cancer Res Treat 2013
190
25

Performance of Three-Biomarker Immunohistochemistry for Intrinsic Breast Cancer Subtyping in the AMBER Consortium.
Emma H Allott, Stephanie M Cohen, Joseph Geradts, Xuezheng Sun, Thaer Khoury, Wiam Bshara, Gary R Zirpoli, C Ryan Miller, Helena Hwang, Leigh B Thorne,[...]. Cancer Epidemiol Biomarkers Prev 2016
40
25

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
25

Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies.
Seungyoun Jung, Molin Wang, Kristin Anderson, Laura Baglietto, Leif Bergkvist, Leslie Bernstein, Piet A van den Brandt, Louise Brinton, Julie E Buring, A Heather Eliassen,[...]. Int J Epidemiol 2016
54
25

Migration patterns and breast cancer risk in Asian-American women.
R G Ziegler, R N Hoover, M C Pike, A Hildesheim, A M Nomura, D W West, A H Wu-Williams, L N Kolonel, P L Horn-Ross, J F Rosenthal,[...]. J Natl Cancer Inst 1993
730
25

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
25


Aggressive estrogen-receptor-positive breast cancer arising in patients with elevated body mass index.
Cesar Augusto Santa-Maria, Jingsheng Yan, Xian-Jin Xie, David Michael Euhus. Int J Clin Oncol 2015
16
25



Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis.
Kylie L Gorringe, Stephen B Fox. Front Oncol 2017
50
25


The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics.
Eugenia E Calle, Carmen Rodriguez, Eric J Jacobs, M Lyn Almon, Ann Chao, Marjorie L McCullough, Heather S Feigelson, Michael J Thun. Cancer 2002
339
25

Invited commentary: screening and the elusive etiology of prostate cancer.
Montserrat Garcia-Closas, Amy Berrington de Gonzalez. Am J Epidemiol 2015
13
25


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.